Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 491

1.

Efficacy and Safety of Sacubitril/Valsartan (LCZ696) Compared With Olmesartan in Elderly Asian Patients (≥65 Years) With Systolic Hypertension.

Supasyndh O, Wang J, Hafeez K, Zhang Y, Zhang J, Rakugi H.

Am J Hypertens. 2017 Jul 11. doi: 10.1093/ajh/hpx111. [Epub ahead of print]

PMID:
28992296
2.

Association between dietary patterns and cognitive function among 70-year-old Japanese elderly: a cross-sectional analysis of the SONIC study.

Okubo H, Inagaki H, Gondo Y, Kamide K, Ikebe K, Masui Y, Arai Y, Ishizaki T, Sasaki S, Nakagawa T, Kabayama M, Sugimoto K, Rakugi H, Maeda Y; SONIC Study Group.

Nutr J. 2017 Sep 11;16(1):56. doi: 10.1186/s12937-017-0273-2.

3.

Effects of Calcium-Channel Blocker Benidipine-Based Combination Therapy on Cardiac Events - Subanalysis of the COPE Trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Shimada K, Kawana M, Kario K, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group.

Circ J. 2017 Sep 2. doi: 10.1253/circj.CJ-17-0592. [Epub ahead of print]

4.

Relationship between atherosclerosis and occlusal support of natural teeth with mediating effect of atheroprotective nutrients: From the SONIC study.

Tada S, Ikebe K, Kamide K, Gondo Y, Inomata C, Takeshita H, Matsuda KI, Kitamura M, Murakami S, Kabayama M, Oguro R, Nakama C, Kawai T, Yamamoto K, Sugimoto K, Shintani A, Ishihara T, Arai Y, Masui Y, Takahashi R, Rakugi H, Maeda Y.

PLoS One. 2017 Aug 17;12(8):e0182563. doi: 10.1371/journal.pone.0182563. eCollection 2017.

5.

Visualization of kidney fibrosis in diabetic nephropathy by long diffusion tensor imaging MRI with spin-echo sequence.

Kaimori JY, Isaka Y, Hatanaka M, Yamamoto S, Ichimaru N, Fujikawa A, Shibata H, Fujimori A, Miyoshi S, Yokawa T, Kuroda K, Moriyama T, Rakugi H, Takahara S.

Sci Rep. 2017 Jul 18;7(1):5731. doi: 10.1038/s41598-017-06111-4.

6.

Comprehensive risk management for the prevention of cerebro- cardiovascular diseases in Japan.

Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro- Cardiovascular Diseases.

Hypertens Res. 2017 Oct 5;40(10):847-855. doi: 10.1038/hr.2016.155. Epub 2017 Jul 13. No abstract available.

PMID:
28701740
7.

Redefining the elderly as aged 75 years and older: Proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society.

Ouchi Y, Rakugi H, Arai H, Akishita M, Ito H, Toba K, Kai I; Joint Committee of Japan Gerontological Society (JGLS) and Japan Geriatrics Society (JGS) on the definition and classification of the elderly.

Geriatr Gerontol Int. 2017 Jul;17(7):1045-1047. doi: 10.1111/ggi.13118. Epub 2017 Jul 2. No abstract available.

PMID:
28670849
8.

Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes.

Pang Z, Kushiyama A, Sun J, Kikuchi T, Yamazaki H, Iwamoto Y, Koriyama H, Yoshida S, Shimamura M, Higuchi M, Kawano T, Takami Y, Rakugi H, Morishita R, Nakagami H.

FASEB J. 2017 Sep;31(9):4053-4063. doi: 10.1096/fj.201700110R. Epub 2017 May 25.

PMID:
28546444
9.

Physician-initiated first-in-human clinical study using a novel angiogenic peptide, AG30/5C, for patients with severe limb ulcers.

Nakagami H, Yamaoka T, Hayashi M, Tanemura A, Takeya Y, Kurinami H, Sugimoto K, Nakamura A, Tomono K, Tamai K, Katayama I, Rakugi H, Kaneda Y.

Geriatr Gerontol Int. 2017 May 10. doi: 10.1111/ggi.13051. [Epub ahead of print]

PMID:
28488306
10.

Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice.

Muratsu J, Iwabayashi M, Sanada F, Taniyama Y, Otsu R, Rakugi H, Morishita R.

Sci Rep. 2017 Mar 9;7(1):130. doi: 10.1038/s41598-017-00199-4.

11.

Longitudinal association of hypertension and diabetes mellitus with cognitive functioning in a general 70-year-old population: the SONIC study.

Ryuno H, Kamide K, Gondo Y, Kabayama M, Oguro R, Nakama C, Yokoyama S, Nagasawa M, Maeda-Hirao S, Imaizumi Y, Takeya M, Yamamoto H, Takeda M, Takami Y, Itoh N, Takeya Y, Yamamoto K, Sugimoto K, Nakagawa T, Yasumoto S, Ikebe K, Inagaki H, Masui Y, Takayama M, Arai Y, Ishizaki T, Takahashi R, Rakugi H.

Hypertens Res. 2017 Jul;40(7):665-670. doi: 10.1038/hr.2017.15. Epub 2017 Feb 23.

PMID:
28230198
12.

Modified forelimb grip strength test detects aging-associated physiological decline in skeletal muscle function in male mice.

Takeshita H, Yamamoto K, Nozato S, Inagaki T, Tsuchimochi H, Shirai M, Yamamoto R, Imaizumi Y, Hongyo K, Yokoyama S, Takeda M, Oguro R, Takami Y, Itoh N, Takeya Y, Sugimoto K, Fukada SI, Rakugi H.

Sci Rep. 2017 Feb 8;7:42323. doi: 10.1038/srep42323.

13.

Prevalence of frailty in Japan: A systematic review and meta-analysis.

Kojima G, Iliffe S, Taniguchi Y, Shimada H, Rakugi H, Walters K.

J Epidemiol. 2017 Aug;27(8):347-353. doi: 10.1016/j.je.2016.09.008. Epub 2016 Nov 15. Review.

14.

Diffusion Tensor Imaging MRI With Spin-Echo Sequence and Long-Duration Measurement for Evaluation of Renal Fibrosis in a Rat Fibrosis Model.

Kaimori JY, Isaka Y, Hatanaka M, Yamamoto S, Ichimaru N, Fujikawa A, Shibata H, Fujimori A, Miyoshi S, Yokawa T, Kuroda K, Moriyama T, Rakugi H, Takahara S.

Transplant Proc. 2017 Jan - Feb;49(1):145-152. doi: 10.1016/j.transproceed.2016.10.014.

PMID:
28104123
15.

On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.

Yano Y, Rakugi H, Bakris GL, Lloyd-Jones DM, Oparil S, Saruta T, Shimada K, Matsuoka H, Imai Y, Ogihara T.

Hypertension. 2017 Feb;69(2):220-227. doi: 10.1161/HYPERTENSIONAHA.116.08600. Epub 2017 Jan 3.

PMID:
28049699
16.

Evaluating the potential of the GFAP-KLH immune-tolerizing vaccine for type 1 diabetes in mice.

Pang Z, Higuchi M, Koriyama H, Yoshida S, Kurinami H, Shimamura M, Takami Y, Rakugi H, Morishita R, Nakagami H.

FEBS Lett. 2017 Jan;591(1):129-136. doi: 10.1002/1873-3468.12511. Epub 2016 Dec 20.

PMID:
27926781
17.

Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group.

Hypertens Res. 2017 Apr;40(4):376-384. doi: 10.1038/hr.2016.158. Epub 2016 Dec 1.

18.

A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke.

Kurinami H, Shimamura M, Nakagami H, Shimizu H, Koriyama H, Kawano T, Wakayama K, Mochizuki H, Rakugi H, Morishita R.

Sci Rep. 2016 Nov 29;6:38062. doi: 10.1038/srep38062.

19.

Risk Evaluation of Postoperative Delirium Using Comprehensive Geriatric Assessment in Elderly Patients with Esophageal Cancer.

Yamamoto M, Yamasaki M, Sugimoto K, Maekawa Y, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Rakugi H, Mori M, Doki Y.

World J Surg. 2016 Nov;40(11):2705-2712.

PMID:
27272271
20.

Activated Factor X Induces Endothelial Cell Senescence Through IGFBP-5.

Sanada F, Taniyama Y, Muratsu J, Otsu R, Iwabayashi M, Carracedo M, Rakugi H, Morishita R.

Sci Rep. 2016 Oct 18;6:35580. doi: 10.1038/srep35580.

Supplemental Content

Loading ...
Support Center